Trials that use: Exact / Clopper-Pearson binomial
New to this method? Read the tutorial →
1,265 results
- TOP 1501Independent statistical analysis of Neoadjuvant Pembrolizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02818920).
- TOP1201 IPIIndependent statistical analysis of Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence…
- TRILUMINATE PivotalIndependent statistical analysis of the TRILUMINATE Pivotal trial of the TriClip device in tricuspid regurgitation, including its hierarchical composite endpoint, win-ratio analysis, KCCQ, functional outcomes, safety, and statistical methodology.
- TURQUOISE-CPBIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4…
- ULT-218Independent statistical analysis of Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03320096).
- Unite-CNMIndependent statistical analysis of Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- urochesterIndependent statistical analysis of Feasibility of the Memory and Attention Adaptation-Training Geriatrics Intervention in Older Cancer Survivors With Mild Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- VELVETIndependent statistical analysis of A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor…
- VERITASIndependent statistical analysis of Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary: primary endpoint…
- VICTORY-AFIndependent statistical analysis of Evaluation of the Phased Radio Frequency Ablation System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01693120).
- VIV-FIHIndependent statistical analysis of EasyCrossTM Device-Self-centering Catheter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06412354).
- VOYAGEIndependent statistical analysis of Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- VOYAGERIndependent statistical analysis of A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- WI223281Independent statistical analysis of Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- X-TRAPIndependent statistical analysis of Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…